HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA lays out 2010 advisory committee slate

This article was originally published in The Tan Sheet

Executive Summary

The agency's tentative 1schedule for advisory committee meetings includes a Food meeting May 20-21 and Pediatric sessions in March, June, September and December. FDA's calendar, published Dec. 30 in the Federal Register, also pencils in meetings for both the Risk Communication panel and Science Board in February, May, August and November. The Nonprescription Drug Advisory Committee has not had tentative or firm meeting dates set. NDAC last met in June 2009 for a joint session regarding acetaminophen with the Drug Safety and Risk Management and Anesthetic and Life Support Drugs committees (2"The Tan Sheet" July 6, 2009)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS135074

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel